reference/3955566

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3955566

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Comparative Study\|Journal Article\|Multicenter Study
endingPage	3858
issn	0732-183X 1527-7755
issueIdentifier	34
pageRange	3851-3858
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3851
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
bibliographicCitation	Hammers HJ, Plimack ER, Infante JR, Rini BI, McDermott DF, Lewis LD, Voss MH, Sharma P, Pal SK, Razak ARA, Kollmannsberger C, Heng DYC, Spratlin J, McHenry MB, Amin A. Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study. J Clin Oncol. 2017 Dec 01;35(34):3851–8. PMID: 28678668; PMCID: PMC7587408.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9db98c12a357d027f2911f865dc2243 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a78ceee67c4de1f3f669589224802d17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f24d1e92d3dbaac4e044d3015977f33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3870415ba8c14f987b01abcdd7ea2974 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_feb444803ffdc0edb47323760d24956d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e1b89dcdaef73da2f7dc38c6ce9a81c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af9cd4fc653055f06c332165879ae8a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0057b52f546380a7b22b327c4e725b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_360819f0d429457f47086a7de4ebb299 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c13318d7e19fd6d0575c318fb6d6f90f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fdd7f68950f44162ea47379ace6f81c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5329d01956a0ee435472a7dc26d6e7be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64bfc5616b7972df81bd46d3328aa958 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d6f51cb2f0ec983119a108ca80dbc84 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79f2b2efc8b734097ecfdbd47375be9c
date	2017-12-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/28678668 https://pubmed.ncbi.nlm.nih.gov/PMC7587408 https://doi.org/10.1200/jco.2016.72.1985
isPartOf	https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
discusses	http://id.nlm.nih.gov/mesh/M000626138 http://id.nlm.nih.gov/mesh/M0585694 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002292Q000401 http://id.nlm.nih.gov/mesh/D002292Q000188 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D007680Q000401 http://id.nlm.nih.gov/mesh/D000074324Q000008 http://id.nlm.nih.gov/mesh/D007680Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009362 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000074324Q000009 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000077594 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D016001 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D002292Q000473 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D020714
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 73 of 73.